Genentech, Inc. (DNA)

Shadow14US (29.32) Submitted: 3/13/08 9:29 PM : Start Price: $80.05 DNA Score: 24.54

Slow starter, good growth. Made 12.91% growth in two months.

Report this Post Replies: 0 | Reply | Permalink

skaskaska (76.36) Submitted: 3/13/08 7:06 PM : Start Price: $80.05 DNA Score: 24.54

Not going away

Report this Post Replies: 0 | Reply | Permalink

forjohnny (71.20) Submitted: 3/13/08 6:20 PM : Start Price: $80.05 DNA Score: 24.54

are you kidding me

Report this Post Replies: 0 | Reply | Permalink

Dtrifan (86.85) Submitted: 11/13/07 9:43 PM : Start Price: $74.71 DNA Score: 38.40

Cancer drugs, tremendous potential

Report this Post Replies: 0 | Reply | Permalink

sundse (86.09) Submitted: 12/07/07 1:19 PM : Start Price: $68.16 DNA Score: 48.45

I like their CEO who seems very sharp. I like the emphasis on autoimmune disease and both basic research in this field and targeted drug development.

They have a good P/E (26) for their projected growth.

Report this Post Replies: 0 | Reply | Permalink

kevrose31 (< 20) Submitted: 12/06/07 2:36 PM : Start Price: $66.11 DNA Score: 51.48

this is too easy.

Report this Post Replies: 0 | Reply | Permalink

Raldogg (45.83) Submitted: 3/14/08 12:40 AM : Start Price: $80.05 DNA Score: 24.54

In the current economic environment, Biotech is one of the safest havens from the precarious credit market. No matter how bad the economy gets people will continue to need their cancer drugs. Within the biotech industry Genentech is by far the best...

Report this Post Replies: 0 | Reply | Permalink

carolinacougar (< 20) Submitted: 11/14/07 12:00 AM : Start Price: $74.71 DNA Score: 38.40

Even in recession will outperform. Great drug coming out.

Report this Post Replies: 0 | Reply | Permalink

gerena19 (32.36) Submitted: 3/14/08 1:53 PM : Start Price: $78.59 DNA Score: 24.35

great stock , will pop soon !


http://www.madmoneyfund.blogspot.com/

Report this Post Replies: 0 | Reply | Permalink

Roosters2006 (49.43) Submitted: 12/05/07 9:48 PM : Start Price: $67.62 DNA Score: -48.41

While I think the explosive growth period is over for this stock, it will still outperforma the market as we are all getting older and the need for more advanced medicines will only increase. DNA is one of the leading players and will lead the way w...

Report this Post Replies: 0 | Reply | Permalink